Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Perry

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|August 21, 2018
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) InhibitorsShuai Liu, Hailemichael O Yosief, Lingling Dai, et al.
Current Biology : CB|February 6, 2007
A role for Cdc2- and PP2A-mediated regulation of Emi2 in the maintenance of CSF arrestQiju Wu, Yanxiang Guo, Ayumi Yamada, et al.
Genes & Development|June 19, 2008
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human diseaseCarl R Walkley, Rameez Qudsi, Vijay G Sankaran, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
Nature Chemical Biology|March 28, 2018
The dTAG system for immediate and target-specific protein degradationBehnam Nabet, Justin M Roberts, Dennis L Buckley, et al.
Nature Chemical Biology|March 7, 2018
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara N Gechijian, Dennis L Buckley, Matthew A Lawlor, et al.
Cancer Discovery|April 11, 2022
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML BlastsJana M Ellegast, Gabriela Alexe, Amanda Hamze, et al.
Cell|November 18, 2006
Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosisSeth S Margolis, Jennifer A Perry, Craig M Forester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myelomaTeru Hideshima, Jun Qi, Ronald M Paranal, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|August 21, 2018
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) InhibitorsShuai Liu, Hailemichael O Yosief, Lingling Dai, et al.
Current Biology : CB|February 6, 2007
A role for Cdc2- and PP2A-mediated regulation of Emi2 in the maintenance of CSF arrestQiju Wu, Yanxiang Guo, Ayumi Yamada, et al.
Genes & Development|June 19, 2008
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human diseaseCarl R Walkley, Rameez Qudsi, Vijay G Sankaran, et al.
Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
Nature Chemical Biology|March 28, 2018
The dTAG system for immediate and target-specific protein degradationBehnam Nabet, Justin M Roberts, Dennis L Buckley, et al.
Nature Chemical Biology|March 7, 2018
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara N Gechijian, Dennis L Buckley, Matthew A Lawlor, et al.
Cancer Discovery|April 11, 2022
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML BlastsJana M Ellegast, Gabriela Alexe, Amanda Hamze, et al.
Cell|November 18, 2006
Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosisSeth S Margolis, Jennifer A Perry, Craig M Forester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2016
Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myelomaTeru Hideshima, Jun Qi, Ronald M Paranal, et al.
Pageof 4